HOME >> BIOLOGY >> NEWS
Multicenter study nets new lung tumor-suppressor gene

BOSTON--Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice. The researchers report in the journal Nature that LKB1 is not only a "tumor-suppressor" gene for non-small cell lung cancer in mice, it also may be more powerful than other, better-known suppressors. The study will be published on the journal's Web site on Aug. 5 and later in a print version.

If further research shows LKB1 has a similar effect in human lung cells, it could influence the way non-small cell lung cancer is diagnosed and treated, says the study's senior author, Kwok-Kin Wong, MD, PhD, of Dana-Farber, one of three institutions, along with Massachusetts General Hospital and the University of North Carolina School of Medicine, leading the work. If tumors with LKB1 mutations are found to be especially fast-growing, for example, patients with such tumors might be candidates for more aggressive therapy.

People born with defective versions of LKB1 often develop Peutz-Jeghers syndrome, which is marked by intestinal growths and an increased risk for certain cancers. Non-inherited mutations of the gene have been found in some lung cancers. This suggested that LKB1 normally thwarts tumors from forming. Mutated versions may be unable to act as a brake on cancer.

To find out, the investigators ran a series of experiments in mice with a defective form of a gene called Kras, which drives the formation and growth of lung cancer. They tracked the development of lung cancer in animals with mutated LKB1 and compared it to the experience of animals with abnormalities in either of two well-known tumor-suppressor genes.

They found that while Kras "cooperated" with the mutated tumor-suppressor genes to produce lung cancer, it cooperated even more strongly with mutated LKB1. The LKB1-deficient tumors grew more rapidly and spread more frequently than the others, and comprised all three
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
5-Aug-2007


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. MIT study: Maturity brings richer memories
9. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
10. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
11. New study demonstrates important role of glia in circadian timing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2019)... ... November 20, 2019 , ... BioInformatics Inc., part of Science and Medicine Group, ... the winners of the Life Science Industry Awards for the most innovative new products ... – Innovation: , Most Innovative New Product – Cell Biology, ...
(Date:11/19/2019)... ... 2019 , ... The inaugural Cell & Gene Therapy Day takes place February ... event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene Therapies ... are witnessing significant innovation in cell and gene therapies, and we are at a ...
(Date:11/14/2019)... (PRWEB) , ... November 13, 2019 , ... Personalized ... the first patients in an FDA approved clinical trial for stem cell treatment ... the formation of the company as a subsidiary of VetStem Biopharma. , In July ...
Breaking Biology News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... Southern ... for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein thrombosis ... benefits for first-in-line treatment for nonsurgical removal of soft emboli and thrombi ...
(Date:12/4/2019)... , ... December 03, 2019 , ... ... products and services, today announced a partnership with the Recombinant Antibody Network (RAN), ... Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released today in STEM CELLS ... reverse fibrosis (scar tissue) buildup – also improves the range of motion of the ... conducted on mice. , The tumor-destroying capabilities of radiation therapy can be a ...
(Date:12/4/2019)... , ... December 04, 2019 , ... The technology at ... a human hair, but its potential impact on the pharmaceutical industry could be massive. ... of biological and chemical engineering at South Dakota School of Mines & Technology ...
Breaking Biology Technology:
Cached News: